Drug Intervention: Researchers Present Final Data From Phase 2 Studies of Soliris® (Eculizumab) in Patients With aHUS

Drug Intervention in the News

Drug Intervention: Researchers Present Final Data from Phase 2 Studies of Soliris® (eculizumab) in Patients with aHUS
CHESHIRE, Conn.–(BUSINESS WIRE)–Alexion Pharmaceuticals today announced the presentation of final data from the two Phase 2 studies of Soliris® (eculizumab) as a treatment for patients with atypical hemolytic uremic syndrome.
Read more on Business Wire



Drug Intervention: The political zombies who walk the halls of Congress
Political scandals don’t always kill the participants. Some survive. Some give up the ghost. Some whose careers have died keep on going.
Read more on Minnesota Public Radio



Drug Intervention: New service for heart attack victims
HEART attack victims could see their chances of survival increase thanks to a new service for patients in South Cumbria.
Read more on North-West Evening Mail

Drug Intervention: “Road to Recovery” KTLA Special Report Drug Intervention Pt. 2



A Better Tomorrow – abttc.net Part 2 of a 5 part KTLA special report of a young mother struggling with her addiction and the road she takes to recovery.
Video Rating: 0 / 5

Find More Drug Intervention Information…